A randomized controlled trial is conducted to evaluate the efficacy of a newly developed calcitonin gene-related peptide (CGRP) receptor antagonist compared to a placebo for the prevention of chronic migraines. Over a -month follow-up period, the incidence of patients progressing to daily migraines in the placebo group was . The investigators report that the new medication provides a relative risk reduction of for this progression compared to the placebo. Based on these findings, what is the number needed to treat with the new medication for months to prevent one additional patient from progressing to daily migraines?
- A2
- B3
- C20
- D34
- 50Answer
Answer
The correct number needed to treat is 50.
The number needed to treat (NNT) is the number of patients who must receive a particular treatment to prevent one additional adverse event. It is calculated as the inverse of the absolute risk reduction (ARR). When given the control event rate (CER) and the relative risk reduction (RRR), the ARR must first be determined by multiplying the two values (). In this scenario, the CER is () and the RRR is (). Thus, the ARR is . The NNT is calculated as , which equals .
Step-by-Step Solution
Key Concept
Calculating Number Needed to Treat (NNT) from baseline risk and relative risk reduction.